Pacira BioSciences' Restructuring Costs rose 48454.13% to $6.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.4 million, marking a year-over-year increase of 120701.63%. This contributed to the annual value of $7.7 million for FY2024, which is 228806.82% up from last year.
Latest data reveals that Pacira BioSciences reported Restructuring Costs of $6.8 million as of Q3 2025, which was up 48454.13% from $634000.0 recorded in Q2 2025.
Pacira BioSciences' Restructuring Costs' 5-year high stood at $10.9 million during Q4 2022, with a 5-year trough of -$1.8 million in Q3 2024.
For the 4-year period, Pacira BioSciences' Restructuring Costs averaged around $2.9 million, with its median value being $1.9 million (2024).
Its Restructuring Costs has fluctuated over the past 5 years, first tumbled by 98300.0% in 2024, then soared by 48454.13% in 2025.
Quarter analysis of 4 years shows Pacira BioSciences' Restructuring Costs stood at $10.9 million in 2022, then crashed by 113.4% to -$1.5 million in 2023, then skyrocketed by 430.6% to $4.8 million in 2024, then soared by 40.6% to $6.8 million in 2025.
Its Restructuring Costs was $6.8 million in Q3 2025, compared to $634000.0 in Q2 2025 and $6.2 million in Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value